Evidence map›Paper›PMID 33350342›Full record

ArticleXenobiotica; the fate of foreign compounds in biological systems2021

Expression of cytochrome P450 isozyme transcripts and activities in human livers.

Jie Liu, Yuan-Fu Lu, J Christopher Corton, Curtis D Klaassen

Open access · greenAbstract read
In one paragraph

Article in Xenobiotica; the fate of foreign compounds in biological systems, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 55 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Drug disposition in cholestasis: An important concern.Pharmacology research & perspectives · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Jie LiuDepartment of Pharmacology, Toxicology & Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA.ORCID https://orcid.org/0000-0002-4530-1443
Yuan-Fu LuKey Lab of Pharmacology of Ministry of Education, Zunyi Medical University, Zunyi, PR China.ORCID https://orcid.org/0000-0002-0698-1597
J Christopher CortonCenter for Computational Toxicology and Exposure, US EPA, Durham, NC, USA.ORCID https://orcid.org/0000-0002-6197-2036
Curtis D KlaassenDepartment of Pharmacology, Toxicology & Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA.
Environmental Protection Agency · USUniversity of Kansas Medical Center · USZunyi Medical University · CN

Funding

THE ROLE OF HUMAN PXR IN ANTI-TUBERCULOSIS DRUG-INDUCED LIVER INJURYP20RR021940 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI KLASSEN, CURTIS D · 2006 to 2011
$12.1M
TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGYT32ES007079 · NIEHS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI HAGENBUCH, BRUNO · 1985 to 2015
$4.1M
Regulation of Hepatic Uptake of Endogenous Signaling Molecules and XenobioticsR01ES009649 · NIEHS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI CSANAKY, IVAN · 2000 to 2014
$4.0M
Regulation of Hepatic Excretion of Xenobiotics by MrpsR01ES009716 · NIEHS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI KLAASSEN, CURTIS DEAN · 2000 to 2010
$3.2M
Coordinate Regulation of Uptake and Efflux TransportersR01ES013714 · NIEHS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI KLAASSEN, CURTIS DEAN · 2006 to 2010
$1.7M
Nrf2 as a Master Regulator in Liver Disease Prevention and TherapyR01DK081461 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI KLAASSEN, CURTIS DEAN · 2009 to 2012
$1.3M
Intramural EPA EPA999999NCRR NIH HHS P20 RR021940NIDDK NIH HHS R01 DK081461NIEHS NIH HHS R01 ES009649NIEHS NIH HHS R01 ES009716NIEHS NIH HHS R01 ES013714NIEHS NIH HHS T32 ES007079
6 · The paper itself

Abstract

Individual differences in cytochrome P450 (CYP) enzymes contribute to responses to drugs and environmental chemicals. The expression of CYPs is influenced by sex, age, and ethnicity. Human CYP studies are often conducted with human liver microsomes and liver cells to evaluate chemical induction and drug interactions. However, the basal or constitutive expression of CYP transcripts and enzyme activities in the intact liver are also important in our understanding of individual variation in CYPs. This study utilised 100 human liver samples to profile the constitutive expression of CYP1A2, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, 3A4, and 4A11 enzyme activity and transcript levels. The mRNA expression of the CYPs and xenobiotic receptors

Indexed as

Cytochrome P-450 Enzyme SystemAgedBlack or African AmericanChildFemaleHispanic or LatinoHumansIsoenzymesLiverMaleWhite PeopleCytochrome P-450 Enzyme SystemIsoenzymesage;CYP mRNA expression;Cytochrome P450 activity;ethnicity;individual variation;sex;

Identifiers

PMID33350342
PMCPMC8215780
OpenAlexW3114647638

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.